MIR8072: A Potential Drug Target and Biomarker for Diseases (G102466877)
MIR8072: A Potential Drug Target and Biomarker for Diseases
MIR8072, also known as hsa-miR-8072, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and biology make it an attractive target for researchers to study and develop new treatments.
MIR8072 is a microRNA (miRNA), a small non-coding RNA molecule that plays a critical role in gene expression. It is expressed in various tissues and cells throughout the body and is involved in regulating various cellular processes, including cell growth, differentiation, and apoptosis.
One of the key features of MIR8072 is its length. It has a length of 29.6 kilobases (kb), which is longer than most miRNAs. This extra length allows for more complex interactions with other molecules, such as proteins, and may increase its stability and stability interactions.
MIR8072 has been shown to play a role in various diseases, including cancer. For example, studies have shown that MIR8072 is downregulated in various types of cancer, including breast, ovarian, and prostate cancer. Additionally, MIR8072 has been shown to be involved in the regulation of cellular processes that are critical for cancer growth, such as cell migration and invasion.
MIR8072 has also been shown to be involved in the regulation of cellular pathways that are important for various diseases, including neurodegenerative diseases. For example, MIR8072 has been shown to be involved in the regulation of dopamine signaling, which is important for the treatment of neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease.
In addition to its potential role in disease, MIR8072 also has potential as a drug target. Studies have shown that MIR8072 can interact with various drug molecules and have been used in various drug screenings. For example, studies have shown that MIR8072 can interact with inhibitors of the protein kinase B, which is involved in cell growth and survival.
MIR8072 has also been shown to have potential as a biomarker for various diseases. For example, studies have shown that MIR8072 can be used as a biomarker for cancer, with higher levels of MIR8072 being associated with more aggressive cancer tumors. Additionally, MIR8072 has been shown to be involved in the regulation of cellular processes that are important for the development and progression of various diseases, including neurodegenerative diseases.
In conclusion, MIR8072 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases. Its unique structure and biology make it an attractive target for researchers to study and develop new treatments. Further research is needed to fully understand the role of MIR8072 in disease and to develop new treatments based on its unique properties.
Protein Name: MicroRNA 8072
The "MIR8072 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR8072 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR8073 | MIR8075 | MIR8076 | MIR8078 | MIR8080 | MIR8082 | MIR8084 | MIR8085 | MIR8087 | MIR8088 | MIR8089 | MIR8485 | MIR873 | MIR874 | MIR875 | MIR876 | MIR877 | MIR885 | MIR887 | MIR888 | MIR889 | MIR890 | MIR891A | MIR891B | MIR892A | MIR892B | MIR892C | MIR9-1 | MIR9-1HG | MIR9-2 | MIR9-3 | MIR9-3HG | MIR920 | MIR921 | MIR922 | MIR924 | MIR924HG | MIR92A1 | MIR92A2 | MIR92B | MIR93 | MIR933 | MIR934 | MIR935 | MIR936 | MIR937 | MIR938 | MIR939 | MIR940 | MIR941-1 | MIR941-2 | MIR941-3 | MIR941-4 | MIR941-5 | MIR942 | MIR943 | MIR944 | MIR95 | MIR96 | MIR98 | MIR99A | MIR99AHG | MIR99B | MIRLET7 | MIRLET7A1 | MIRLET7A2 | MIRLET7A3 | MIRLET7B | MIRLET7BHG | MIRLET7C | MIRLET7D | MIRLET7E | MIRLET7F1 | MIRLET7F2 | MIRLET7G | MIRLET7I | MIS12 | MIS12 complex | MIS18A | MIS18A-AS1 | MIS18BP1 | MISFA | MISP | MISP3 | MITD1 | MITF | Mitochondrial complex I assembly complex | Mitochondrial import inner membrane translocase 23 (TIM23) complex | Mitochondrial inner membrane protease complex | Mitochondrial membrane ATP synthase | Mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) | Mitochondrial pyruvate carrier complex (MPC) | Mitochondrial RNA processing endoribonuclease | Mitofilin Complex | Mitofusin | Mitogen-Activated Protein Kinase | Mitogen-activated protein kinase (JNK) | Mitogen-Activated Protein Kinase (MAP Kinase)-Activated Protein Kinase | Mitogen-Activated Protein Kinase Kinase Kinase (MAP3K) | Mitogen-activated protein kinase p38 (MAPK p38)
